- Pro Medicus (ASX:PME) inks eight-year contract with the Oregon Health & Science University (OHSU), valued at $20 million
- The contract follows a transactional licensing model, involving the implementation of Pro Medicus’ cloud-engineered solution, Visage 7
- OHSU encompasses a total of 576 licensed beds and employs a workforce of nearly 20,000 staff members
- Visage 7 also plays a role in providing the enterprise-wide distribution of images, seamlessly integrated into OHSU’s electronic health record (EHR) system
- PME shares are up .75 per cent, trading at $85.82 at 12:17 pm AEDT
Leading health imaging company Pro Medicus (ASX:PME), through its US subsidiary, has inked an eight-year contract with the Oregon Health & Science University (OHSU), valued at $20 million.
OHSU, Oregon’s primary academic medical centre, encompasses both OHSU Hospital and OHSU Doernbecher Children’s Hospital, with a combined total of 576 licensed beds and a workforce of nearly 20,000 staff members.
The contract follows a transactional licensing model, involving the implementation of Pro Medicus’ cloud-engineered solution, Visage 7, including Visage 7 Open Archive and Visage 7 Workflow modules, across OHSU to establish a unified diagnostic imaging platform.
“OHSU adds to our rapidly growing list of clients in the Pacific Northwest, they also join a long list of Visage 7 clients to opt for a fully cloud-engineered solution, which, as a result of our CloudPACS strategy, is becoming the standard in the North American healthcare IT market,” PME CEO Dr Sam Hupert said.
“Our pipeline remains strong and spans all market segments. This deal is for our ‘full-stack’ comprising all three Visage products namely viewer, workflow and archive, a trend we see continuing.”
Visage 7 will also play a role in providing the enterprise-wide distribution of images, seamlessly integrated into OHSU’s electronic health record (EHR) system.
PME shares were up .75 per cent, trading at $85.82 at 12:17 pm AEDT.